A Phase III, Double-blind, Placebo-controlled, Multicenter Study on the Efficacy of Recombinant Human Antithrombin in Heparin-resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass
2005
Background:The study evaluated the efficacy of recombinant human antithrombin (rhAT) for restoring heparin responsiveness in heparin resistant patients undergoing cardiac surgery.Methods:This was a multicenter, randomized, double-blind, placebo-controlled study in heparin-resistant patients undergoi
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
47
References
101
Citations
NaN
KQI